- Sernova Corp Business Update, Strategy and Outlook Call TranscriptOct 05, 2023
- Sernova Corp Introduction of the New CEO and Recently Appointed Chief Business Officer Call TranscriptSep 22, 2023
- Sernova Corp Cell & Gene Meeting on the Med 2023 TranscriptJun 01, 2023
- Sernova Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Sernova Corp at ROTH Conference TranscriptMar 13, 2023
- Sernova Corp To Discuss on Regenerative Therapeutics to Develop Functional Cures TranscriptOct 11, 2022
- Sernova Corp at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Evotec SE and Sernova Corp to Discuss Exclusive Strategic Partnership M&A Call TranscriptMay 17, 2022
- Sernova Corp CEO Roadshow TranscriptDec 10, 2020
- Sernova Corp At TSX Life Sciences Investor Day TranscriptOct 30, 2020
- Sernova Corp at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 13, 2020
- Sernova Corp At ADA Scientific Sessions TranscriptJun 13, 2020
- Sernova Corp At CEO Conference Call TranscriptMay 29, 2020
Sernova Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Good afternoon, and welcome to the next session of Oppenheimer's Annual Healthcare Conference. I'm Shaymus Contorno from the medtech research team. Next up, we're pleased to have CEO, Phil Toleikis, from Sernova for a presentation.
With that, I'll turn it over to you Phil. I'll resurface with about five minutes left for some Q&A. And, to you.
Thank you very much and good to be here today. So Sernova is a cell therapeutics company, and we're at the clinical stage. And our goal is to provide functional cures for a number of chronic serious diseases. We are listed on the Toronto Stock Exchange under the symbol SVA, where most of our shares are trading. But we're also on the OTCQB under the symbol SEOVF. And we have aspirations in the near future to be listing on NASDAQ. Please be aware of the forward-looking statements.
So Sernova is a cell therapeutics company and what we are working on is treatment of high-maintenance, lifelong
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)